Tag : IDEAYA Biosciences

Clinical Research, Pharma & Healthcare Financing

IDEAYA Begins Phase 1 Trial of IDE574 for Multiple Tumors

PR Newswire
by PR Newswire027
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been enrolled in its Phase 1 dose escalation...